Insiders · KZIA

James E. Levine

Chief Financial Officer at Kazia Therapeutics Ltd (KZIA) since June 2026

James E. Levine has filed 11 insider reports with the SEC since March 2021, as chief Financial Officer at Kazia Therapeutics Ltd (KZIA), chief Financial Officer at Cardiff Oncology, Inc. (CRDF) and officer at Cidara Therapeutics, Inc. (CDTX). James E. Levine made no open-market purchases or sales in the last 12 months. The latest filing, on June 23, 2026, reports grant or award at Kazia Therapeutics Ltd (KZIA).

Filings
11
Companies
3
Bought on market
$277K
Sold on market
None

Companies where James E. Levine is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
Kazia Therapeutics Ltd logo
KZIA
Kazia Therapeutics Ltd
Chief Financial Officersince June 2026$5.49Jun 23, 2026
Cardiff Oncology, Inc. logo
CRDF
Cardiff Oncology, Inc.
Chief Financial Officersince July 202160,000$277K$4.10$0.839-80%Mar 13, 2025
Cidara Therapeutics, Inc. logo
CDTX
Cidara Therapeutics, Inc.
Officer69,803Mar 20, 2021

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Compare James E. Levine with

Other insiders at the same companies

Questions about James E. Levine

What is James E. Levine's role at Kazia Therapeutics Ltd?
James E. Levine reports to the SEC as chief Financial Officer at Kazia Therapeutics Ltd (KZIA), according to the latest filing on June 23, 2026. James E. Levine has also filed as chief Financial Officer at Cardiff Oncology, Inc. (CRDF) and officer at Cidara Therapeutics, Inc. (CDTX).
How many shares does James E. Levine own?
After the latest filing that states it, James E. Levine directly owned 60,000 shares of Cardiff Oncology, Inc. (CRDF) and 69,803 shares of Cidara Therapeutics, Inc. (CDTX). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has James E. Levine bought or sold stock recently?
The most recent open-market purchase was on December 18, 2024: bought 7,716 shares of Cardiff Oncology, Inc. (CRDF) for $36.7K at an average of $4.76.
How do I get alerts when James E. Levine files?
Follow James E. Levine on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by James E. Levine (SEC CIK 0001463151). Totals count each trade once, skipping amendments whose original is on file, from Mar 20, 2021 on. View on SEC EDGAR